Immunotoxins and Antibody-Drug Conjugates for Cancer Treatment-Reference-Cited by-同舟云学术

Immunotoxins and Antibody-Drug Conjugates for Cancer Treatment

Published:2002 Issue: Volume: Page:291-309
ISSN:
Container-title:Biomedical Aspects of Drug Targeting
language:
Short-container-title:

Author:

Goldmacher Victor S.,Blättler Walter A.,Lambert John M.,Chari Ravi V. J.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4757-4627-3_15.pdf

Reference46 articles.

1. Pietersz, G. A., Krauer, K., and McKenzie, I. F. The use of monoclonal antibody immunoconjugates in cancer therapy. Adv Exp Med Biol, 353: 169–179, 1994.

2. Chari, R. V. Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy. Adv Drug Deliv Rev, 31: 89–104, 1998.

3. Guillemard, V. and Saragovi, H. U. Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res, 61: 694699, 2001.

4. Chari, R. V., Martell, B. A., Gross, J. L., Cook, S. B., Shah, S. A., Blättler, W. A., McKenzie, S. J., and Goldmacher, V. S. Immunoconjugates containing novel maytansinoids: promising anticancer drugs. Cancer Res, 52: 127–131, 1992.

5. Pietersz, G. A. The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer. Bioconjug Chem, 1: 89–95, 1990.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Therapeutic Modes;New Nanomaterials and Techniques for Tumor-targeted Systems;2020

2. Antibody-drug Conjugates (ADCs);Methods and Principles in Medicinal Chemistry;2017-08-14

3. Mass Spectrometry of Antibody–Drug Conjugates in Plasma and Tissue in Drug Development;Characterization of Protein Therapeutics using Mass Spectrometry;2013

4. Biological Treatments (Antibodies);Head & Neck Cancer: Current Perspectives, Advances, and Challenges;2013

5. Antibody–drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells;Therapeutic Delivery;2011-03